Identity
- Type
- company
- Country label
- not in the notes
- HQ country
- not in the notes
- Founding country
- not in the notes
- Parent
- not in the notes
- Parent country
- not in the notes
- Country basis
- the research notes
Where this comes from
Convention D1: a dual label, HQ first, when the HQ, founding or parent country differ.
Models by Class
Models
ModelClassOpennessParametersReleased
Boltz-2Boltz PBC, MIT (Jameel Clinic), RecursionscientificJun 2025
OpenPhenom-S/16scientific21 Oct 2024Links
OrganisationRecursioncompany
RecursioncompanyWho Runs It
PfizerContract signed, 8 Jan 2026
PfizerContract signed, 8 Jan 2026Scores
| Benchmark | Model | Score | Who ran it | Setting |
|---|---|---|---|---|
| FEP+/OpenFE binding affinity benchmark | Boltz-2 | 0.62 Pearson r | vendor-reported | About 0.62; about 1,000x faster than FEP |
Where this comes from
Every recorded score of this organisation's models, with who ran it. Scores from different settings are not directly comparable.
Sources
- Open source protein models: OpenFold vs Boltz scalingbiotech.substack.com https://scalingbiotech.substack.com/p/open-source-protein-models-openfold
To cite this page: Project AURION, AI Use-Cases Research & Innovation, "Recursion", https://aurion.semai.id/organisations/recursion/, records of October 2026.